{"pub_date": "2016-02-11T00:00:00Z", "subsection_name": "DealBook", "lead_paragraph": "Mylan is buying greater exposure to over-the-counter products, which represent 40 percent of Meda\u2019s product sales, and an entry into emerging markets.", "print_page": null, "document_type": "article", "byline": {"person": [{"rank": 1, "organization": "", "lastname": "PICKER", "firstname": "Leslie", "role": "reported"}], "original": "By LESLIE PICKER"}, "multimedia": [], "section_name": "Business Day", "headline": {"main": "Mylan in $7.2 Billion Deal for Meda, a Swedish Drug Maker"}, "source": "The New York Times", "blog": [], "word_count": "436", "web_url": "http://www.nytimes.com/2016/02/11/business/dealbook/mylan-in-7-2-billion-deal-for-meda-a-swedish-drug-maker.html", "slideshow_credits": null, "news_desk": "Business", "type_of_material": "News", "snippet": "Mylan is buying greater exposure to over-the-counter products, which represent 40 percent of Meda\u2019s product sales, and an entry into emerging markets.", "_id": "56bbbad238f0d862fbbced39", "abstract": null, "keywords": [{"rank": "1", "name": "organizations", "value": "Mylan Inc", "is_major": "N"}, {"rank": "2", "name": "organizations", "value": "Meda AB", "is_major": "N"}, {"rank": "3", "name": "subject", "value": "Mergers, Acquisitions and Divestitures", "is_major": "N"}, {"rank": "4", "name": "subject", "value": "Drugs (Pharmaceuticals)", "is_major": "N"}]}